Company Description : A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system. url: www.repligen.com
Presentation of North America's First Certificate for BS 25999, the New Standard for Business Continuity : RESTON, Va., July 8 /PRNewswire/ -- BSI announced today that Repligen Corporation, Waltham, MA (NASDAQ:RGEN); the world's leading supplier of recombinant Protein A, a consumable used in the manufacture of monoclonal antibodies...
Register for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.
Get the Latest Repligen stock Price, quotes, trades and FREE Repligen stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Repligen (RGEN) and other NASDAQ Stock Market listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.